Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Todd Borenstein

Orthopaedic Surgery Providence, RI Medical Doctor

NPI 1881914653 CMS profile 267540

2 Dudley St, Suite 200, Providence, RI 02905

Open in the dashboard

General payments

$49,412

107 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Todd Borenstein of Providence, RI is reported in the CMS Open Payments database as having received $49,412 across 107 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,426 27
2024 General $10,975 6
2023 General $25,088 22
2022 General $3,179 20
2021 General $4,158 26
2020 General $3,587 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Todd Borenstein
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Todd Borenstein were reported at $2,426. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Todd Borenstein Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $3,587 $312 $75–$1,860 $114
2021 $4,158 $520 $117–$2,495 $132
2022 $3,179 $598 $128–$2,731 $149
2023 $25,088 $461 $128–$2,264 $160
2024 $10,975 $497 $134–$2,475 $164
2025 $2,426 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Globus Medical, Inc. $38,026 38 payments
  2. Micromed Inc $4,045 8 payments
  3. Arthrex, Inc. $3,357 19 payments
  4. Stryker Corporation $2,120 28 payments
  5. Advanced Orthopaedic Solutions, Inc. $1,387 2 payments
  6. NuVasive Specialized Orthopedics, Inc. $126 1 payment
  7. Bioventus LLC $119 2 payments
  8. Treace Medical Concepts, Inc. $99 4 payments
  9. Smith+Nephew, Inc. $49 1 payment
  10. Dynasplint Systems Inc. $37 2 payments
  11. Other $47 2 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,600 3 payments
  2. Consulting Fee $10,456 8 payments
  3. Travel and Lodging $7,358 18 payments
  4. Education $5,701 5 payments
  5. Food and Beverage $4,297 73 payments
Products named General payments · program years 2020–2025
  1. Foot System $20,925 7 payments
  2. Anthem Orthopedics/Orthopedic Surgery $10,700 3 payments
  3. Ankle Fracture System $2,662 6 payments
  4. AOS PRODUCTS $1,387 2 payments
  5. Anthem Orthopedics/Orthopedic Surgery $1,273 3 payments
  6. ANCHORAGE $1,163 9 payments
  7. Clavicular Fracture Fixation $1,090 3 payments
  8. Excelsius Robotics System $760 2 payments
  9. GAMMA $376 7 payments
  10. PANGEA $253 5 payments
  11. Other $1,457 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

182

Median for Orthopedic Surgery: 203

Drug cost

$1,281

Median for Orthopedic Surgery: $1,433

Branded share of claims

35.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 44 $418
Tramadol Hcl Generic 39 $318
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 21 $203
Ibuprofen Generic 47 $194
Doxycycline Hyclate Generic 20 $124
Meloxicam Generic 11 $24

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 150 billing codes

Paid by Medicare

$160,120

Of which drugs: $13,574

Medicare patients

303

Average age 75

Services billed

5,821

206 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 68%
Diabetes 36%
Ischemic heart disease 33%
Osteoporosis 32%
Depression 31%
Chronic kidney disease 30%
Heart failure 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 58 324 $1,707
Injection, methylprednisolone acetate, 1 mg J1010 Office 46 3,171 $323
Injection, methylprednisolone acetate, 40 mg J1030 Office 20 47 $219

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

107 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Rhode Island

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record